These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 34762931)

  • 1. One-hundred year evolution of prandial insulin preparations: From animal pancreas extracts to rapid-acting analogs.
    Bolli GB; Porcellati F; Lucidi P; Fanelli CG; Owens DR
    Metabolism; 2022 Jan; 126():154935. PubMed ID: 34762931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prandial Insulins: A Person-Centered Choice.
    Attri B; Nagendra L; Dutta D; Shetty S; Shaikh S; Kalra S; Bhattacharya S
    Curr Diab Rep; 2024 Jun; 24(6):131-145. PubMed ID: 38568467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A 50-year history of new drugs in Japan-the development and progress of anti-diabetic drugs and the epidemiological aspects of diabetes mellitus].
    Ozawa H; Murai Y; Ozawa T
    Yakushigaku Zasshi; 2003; 38(1):11-27. PubMed ID: 14570054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The continuing quest for better subcutaneously administered prandial insulins: a review of recent developments and potential clinical implications.
    Owens DR; Bolli GB
    Diabetes Obes Metab; 2020 May; 22(5):743-754. PubMed ID: 31930670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolution of insulin development: focus on key parameters.
    Tibaldi JM
    Adv Ther; 2012 Jul; 29(7):590-619. PubMed ID: 22843207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin formulations--a review.
    Gualandi-Signorini AM; Giorgi G
    Eur Rev Med Pharmacol Sci; 2001; 5(3):73-83. PubMed ID: 12004916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of ultrafast-acting insulin analogues in the management of diabetes.
    Kruger DF; Novak LM
    J Am Assoc Nurse Pract; 2019 Sep; 31(9):537-548. PubMed ID: 31385938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combining insulins for optimal blood glucose control in type I and 2 diabetes: focus on insulin glulisine.
    Ulrich H; Snyder B; Garg SK
    Vasc Health Risk Manag; 2007; 3(3):245-54. PubMed ID: 17703632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What is the value of faster acting prandial insulin? Focus on ultra rapid lispro.
    Heise T; Piras de Oliveira C; Juneja R; Ribeiro A; Chigutsa F; Blevins T
    Diabetes Obes Metab; 2022 Sep; 24(9):1689-1701. PubMed ID: 35593434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of rapid-acting insulin analogues in the treatment of patients with type 1 and type 2 diabetes mellitus: insulin pump therapy versus multiple daily injections.
    Bode BW
    Clin Ther; 2007; 29 Suppl D():S135-44. PubMed ID: 18191065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin lispro: a fast-acting insulin analog.
    Noble SL; Johnston E; Walton B
    Am Fam Physician; 1998 Jan; 57(2):279-86, 289-92. PubMed ID: 9456992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid-acting insulin analogues in Basal-bolus regimens in type 1 diabetes mellitus.
    Garg S; Ampudia-Blasco FJ; Pfohl M
    Endocr Pract; 2010; 16(3):486-505. PubMed ID: 20150026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin glulisine.
    Robinson DM; Wellington K
    Drugs; 2006; 66(6):861-9. PubMed ID: 16706558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoglycemia and insulin analogues: is there a reduction in the incidence?
    Heinemann L
    J Diabetes Complications; 1999; 13(2):105-14. PubMed ID: 10432175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin glulisine: an evaluation of its pharmacodynamic properties and clinical application.
    Helms KL; Kelley KW
    Ann Pharmacother; 2009 Apr; 43(4):658-68. PubMed ID: 19336657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Superiority of insulin analogues versus human insulin in the treatment of diabetes mellitus.
    Rossetti P; Porcellati F; Fanelli CG; Perriello G; Torlone E; Bolli GB
    Arch Physiol Biochem; 2008 Feb; 114(1):3-10. PubMed ID: 18465353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New insulins in the treatment of diabetes mellitus.
    Lindholm A
    Best Pract Res Clin Gastroenterol; 2002 Jun; 16(3):475-92. PubMed ID: 12079270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and Safety of Rapid-Acting Insulin Analogs in Special Populations with Type 1 Diabetes or Gestational Diabetes: Systematic Review and Meta-Analysis.
    Nørgaard K; Sukumar N; Rafnsson SB; Saravanan P
    Diabetes Ther; 2018 Jun; 9(3):891-917. PubMed ID: 29623593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The quest for physiologic insulin replacement.
    Owens DR
    Postgrad Med; 2004 Nov; 116(5 Suppl Exploring):4-12. PubMed ID: 19667674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin preparations with prolonged effect.
    Owens DR
    Diabetes Technol Ther; 2011 Jun; 13 Suppl 1():S5-14. PubMed ID: 21668337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.